v3.25.0.1
Accrued Liabilities Detail - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Accrued Liabilities, Current [Abstract]    
Accrued compensation $ 13,305 $ 5,918
Cystic Fibrosis Foundation liability 7,443 7,633
Income tax payable   641
Current portion of operating lease liability $ 3,552 $ 4,309
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total Total
Clinical trial accruals $ 2,828 $ 2,333
Vinbiocare contractual liabilities 2,421 2,514
Legal accrual 130 177
Other accrued research and development expenses 9,102 8,356
Total $ 38,781 $ 31,881